WorldPing logo WorldPing← All news

STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and moreWorldPing
Image via STAT.

What happened

During a Senate hearing today, Heidi Overton, the nominee to lead the FDA, plans to emphasize the need for speed and efficiency to compete with China…

Key facts

  • Reported by STAT and published Thu, 24 Sep 2026 13:21:50 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: How a young doctor rose from rural New Mexico to FDA commissioner nominee

  2. STAT+: Why Gilead can’t stop talking about its ambitions in immunology

  3. STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage